Summary
Packet for drug Tryparsamide. Made by Pharmaceutical Specialties [May & Baker] Ltd., Dagenham, England, circa 1925, by arrangement with the Rockefeller Institute for Medical Research. Kept in a mental health hospital pharmacy and administered to patients at a mental health hospital in Victoria, Australia. Tryparsamide (trade name) is sodium N-phenylglycineamide-p-arsonate, a compound containing 25% arsenic. Used in conjunction with malarial fever therapy to treat tertiary neuro-syphilis in patients diagnosed with General Paralysis of the Insane (GPI), having been originally developed for the treatment of human African trypanosomiasis, or African sleeping sickness. GPI was found to be caused by the spirochaete bacterium Treponema pallidum and later treated effectively with penicillin.
Physical Description
Brown cardboard packet with blue printed text. Box is empty. Though a specific reference could not be found in the 'Standard for the uniform scheduling of drugs and poisons' (Australian Government Publishing Service, Canberra 1999) it is suspected that, given the arsenic salt ingredient, this pharmaceutical product would be classified as S6 (Poison) or S7 (Dangerous Poison).
More Information
-
Collection Names
-
Collecting Areas
-
Acquisition Information
Donation from Office of Psychiatric Services, May 1985
-
Manufacturer
May & Baker Ltd, Dagenham, Essex, England, Great Britain, circa 1925
-
Place Made
Rockefeller Institute of Medical Research, New York, New York State, United States of America, circa 1925
-
Place Used
-
Inscriptions
Text: 3 Grammes/TRYPARSAMIDE/N.Phenylglycineamide-p-arsonate.
-
Classification
Medicine & health, Mental health - pharmacy, Pharmaceuticals
-
Category
-
Discipline
-
Type of item
-
Overall Dimensions
114 mm (Length), 28 mm (Width), 28 mm (Height)
-
Overall Dimensions - Folded
110 mm (Length), 27 mm (Width), 27 mm (Height)
Measurement From Conservation.
-
Keywords
Hospitals, Psychiatric Services, Pharmaceuticals, Psychiatric Hospitals, Psychiatric Institutions, Drugs, Medicinals & Drugs, Medicines, Mental Health, Mental Health Institutions, Syphilis, Sexually Transmitted Diseases (STDs), Diseases, Packaging